Education
About Us
Working with TipRanks
Follow Us
ADMA Biologics Inc (ADMA)
:ADMA
Earnings Data
Report Date
Mar 19, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.19Last Year’s EPS
0.14Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call reflects a strong overall performance with record revenue growth, successful product utilization, and promising future prospects. Despite some temporary challenges in the IVIG market and a negative margin plasma sale, the company's strategic initiatives and financial outlook are positive.Company Guidance
Record Revenue Growth
ADMA Biologics reported a total revenue of $134.2 million for Q3 2025, representing a 10% quarter-over-quarter increase and 12% growth year-over-year.
ASCENIV Utilization and Clinical Data
ASCENIV showed record utilization and a greater than 50% reduction in infection rates in patients transitioning from standard IG therapy, suggesting enhanced protection against infections.
Yield Enhanced Production
FDA's release of yield enhanced production batches is expected to improve batch output by 20%, driving sustained gross margin expansion starting in Q4 2025.
Strong Financial Outlook
ADMA raised its 2025 revenue guidance to $510 million and expects 2026 revenue to be at least $630 million, highlighting strong future growth expectations.
SG-001 Program Progress
The SG-001 program is advancing with potential to address unmet medical needs and is expected to be a key value driver with IP protection through at least 2037.
ADMA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ADMA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $15.37 | $14.03 | -8.72% |
Aug 06, 2025 | $18.54 | $16.75 | -9.65% |
May 07, 2025 | $23.61 | $21.20 | -10.21% |
Mar 03, 2025 | $15.83 | $17.01 | +7.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does ADMA Biologics Inc (ADMA) report earnings?
ADMA Biologics Inc (ADMA) is schdueled to report earning on Mar 19, 2026, TBA (Confirmed).
What is ADMA Biologics Inc (ADMA) earnings time?
ADMA Biologics Inc (ADMA) earnings time is at Mar 19, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ADMA EPS forecast?
ADMA EPS forecast for the fiscal quarter 2025 (Q4) is 0.19.